← Back to your selection

Catalio Capital Management

Activity from announced rounds

Activity in this selectionJun 30, 2021 · Jun 1, 2021

Catalio Capital Management is an investment manager whose official company communications identify BigHat Biosciences and Basecamp Research.

Recorded funding activity

BigHat combines AI and synthetic biology to engineer antibody therapeutics. Basecamp builds biological models from genomic data for therapeutic design, while Enveda discovers biologically active molecules from nature. The financings represent different routes from biological data to experimental medicines.

Sources
Rounds participated in
0
Confirmed lead rounds
—
All roles disclosed
New companies
0
First participation on record · 0 follow-on
Funding in participating rounds
—
0 disclosed · full round size, not this investor’s share

By stage

No activity in this selection.

By primary sector

No activity in this selection.

By country

No activity in this selection.

Rounds

0 in this selection

No rounds match this selection.